<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="370433">
  <stage>Registered</stage>
  <submitdate>30/03/2016</submitdate>
  <approvaldate>6/05/2016</approvaldate>
  <actrnumber>ACTRN12616000591459</actrnumber>
  <trial_identification>
    <studytitle>The efficacy of intravenous ibuprofen and pregabalin before posterior lumbar stabilisation surgery on postoperative pain.</studytitle>
    <scientifictitle>Comparison of pregabalin  and pregabalin+ intravenous ibuprofen for preemptive (before the procedure) analgesia for posterior lumbar stabilisation operation.</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Lumbar stabilisation procedures</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Pain management</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>For postoperative pain we will give one group of patients ( 21 patients for each group) pregabalin 150 mg oral form 1 hour before the operation. The other group will take pregabalin like group 1 and intravenous ibuprofen 800 mg, 1/2 hour before the operation.</interventions>
    <comparator>Group 1 (pregabalin only) is the control group.</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>postoperative analgesia which evaluated by 100 mm Visual Analog Scale (VAS)</outcome>
      <timepoint>postoperative 0,1,2,4,8,12,24,36,48. hour.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Patient satisfaction score which evaluated by 100 mm visual analog scale.</outcome>
      <timepoint>24. and 48. postoperative hour.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>ASA ( american society of anesthesiologists) Physical Status 1-2, 
planned for elective posterior lumbar stabilisation surgery  </inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>65</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Antiepileptic drug use, ASA 3 patient groups, Mild or severe renal insufficiency.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate />
    <actualstartdate>1/06/2016</actualstartdate>
    <anticipatedenddate>1/09/2016</anticipatedenddate>
    <actualenddate>20/09/2016</actualenddate>
    <samplesize>42</samplesize>
    <actualsamplesize>42</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>22/09/2016</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Turkey</country>
      <state>Konya</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Baskent University</primarysponsorname>
    <primarysponsoraddress>Taskent Caddesi (Eski 1. Cadde) 77. Sokak (Eski 16. Sokak) No:11 06490 Bahcelievler / ANKARA / Turkey</primarysponsoraddress>
    <primarysponsorcountry>Turkey</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>Baskent University Research Fund</fundingname>
      <fundingaddress>Taskent Caddesi (Eski 1. Cadde) 77. Sokak (Eski 16. Sokak) No:11 06490 Bahcelievler / ANKARA / Turkey</fundingaddress>
      <fundingcountry>Turkey</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>For managing acute postoperative pain, new medical treatments administered preoperatively. For this purpose, pregabalin has been used previously for lumbar fusion surgery in some clinical research. Intravenous ibuprofen ( NSAID analgesic) used until 2009. We want to investigate the effect of pregabalin+intravenous ibuprofen used before the operation preemptively on postoperative analgesia for lumbar fusion surgery.
We enroll 42 patients who undergone elective lumbar fusion surgery. Exclusion criteria; antiepileptic drug use, allergic reaction for study drugs, ASA III-IV patients. mild or severe renal insufficiency.
Group Pregabalin: 1 hour before operation patients will take 150 mg pregabalin oral form.
Group Pregabalin + intravenous ibuprofen: 1 hour before operation patients will take 150 mg pregabalin oral form. Additionally 1/2 hour before operation patients will take 800 mg intravenous ibuprofen.
After operation we give patient controlled analgesia contains morphine, and we will evaluate postoperative pain.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>baskent University Institutional Review Board and Ethics Committee</ethicname>
      <ethicaddress>Taskent Caddesi (Eski 1. Cadde) 77. Sokak (Eski 16. Sokak) No:11 06490 Bahcelievler / ANKARA / Turkey</ethicaddress>
      <ethicapprovaldate>18/03/2016</ethicapprovaldate>
      <hrec>KA 16/71</hrec>
      <ethicsubmitdate>1/02/2016</ethicsubmitdate>
      <ethiccountry>Turkey</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>huseyin ulas pinar</name>
      <address>Baskent University Konya Research and Application Center Hocacihan Mah Saray cad no:1 42080 selcuklu/Konya</address>
      <phone>+903322570606</phone>
      <fax>+903322570637</fax>
      <email>huseyinpinar2002@yahoo.com</email>
      <country>Turkey</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Mr</title>
      <name>huseyin ulas pinar</name>
      <address>Baskent University Konya Research and Application Center Hocacihan mah saray cad no:1 42080 selcuklu/Konya</address>
      <phone>+903322570606</phone>
      <fax>+903322570637</fax>
      <email>huseyinpinar2002@yahoo.com</email>
      <country>Turkey</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Mr</title>
      <name>huseyin ulas pinar</name>
      <address>Baskent University Konya Research and Application Center hocacihan mah saray cad no:1 42080 selcuklu/Konya</address>
      <phone>+903322570606</phone>
      <fax>+903322570637</fax>
      <email>huseyinpinar2002@yahoo.com</email>
      <country>Turkey</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>